Development of novel therapeutic strategies for AIDS by the molecular regulation strategies for feline immunodeficiency virus infection

通过猫免疫缺陷病毒感染的分子调控策略开发艾滋病新治疗策略

• 批准号: 15380209
• 负责人: TSUJIMOTO Hajime
• 金额: $ 8.26万
• 依托单位: The University of Tokyo
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (B)
• 财政年份: 2003
• 资助国家: 日本
• 起止时间: 2003 至 2004
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15380209/
• 关键词: cat; feline immunodeficiency virus; antiviral therapy; RNA interference; chemokine receptor; fusion inhibitor; dendritic cell; animal model; 猫免疫不全ウイルス; 遺伝子治療; 免疫療法; small interfering RNA; 骨髄内投与; レトロウイルスベクター; ネコ; 感染症; 治療

A series of studies were performed in order to develop novel therapeutic strategies specific to feline immunodeficiency virus (FIV) infection.1. A therapeutic strategy using RNA interference was employed to inhibit the gene expression of FIV. Transfection of plasmid vectors expressing FIV-specific shRNA into FIV-infected feline cell lines resulted in the consistent suppression of the expression of FIV mRNA/protein and reverse transcriptase.2. Antiviral effect of several types of CXC-chemokine receptor inhibitors (CXCR4 antagonists) was investigated. C-terminal amidated CXCR4 antagonists synthesized to increase the biostability showed a significant activity to inhibit the replication of FIV.3. Antiviral effect of the fusion-associated heptad repeat and its derivatives of FIV gp40 was examined. The study revealed several fusion peptides that showed strong antiviral effect for various FIV strains of different subtypes.4. To develop immunotherapy using dendritic cells (DC), feline peripheral blood monocytes were cultured in the presence of various cytokines. These cells were shown to have dendritic projections and immunological phenotypes characteristic to DC. Function of DC was maintained in asymptomatic carrier cats infected with FIV.The present study provided innovative findings to develop antiviral therapies in FIV infection. With respect to the RNA interference, viral receptor, membrane fusion, and DC, there is a remarkable similarity between FIV infection in cats and AIDS in humans ; thus, the results obtained in this study can be also useful to utilize the feline system as an animal model of AIDS in humans.

开展了一系列研究，以开发针对猫免疫缺陷病毒(FIV)感染的新治疗策略。采用RNA干扰的治疗策略抑制FIV的基因表达。结论1.将表达FIV特异性shRNA的质粒载体导入FIV感染的猫细胞系，可持续抑制FIV mRNA/蛋白的表达和逆转录酶的表达。研究了几种CXC趋化因子受体抑制剂(CXCR4拮抗剂)的抗病毒作用。合成的C端酰胺化CXCR4拮抗剂具有明显的抑制FIV复制的活性。检测融合七肽重复序列及其衍生的FIV gp40的抗病毒作用。研究发现，多个融合多肽对不同亚型的不同FIV毒株均显示出较强的抗病毒作用。为了开发树突状细胞(DC)的免疫治疗，将猫外周血单核细胞培养在各种细胞因子的存在下。这些细胞具有树突状突起和树突状细胞特有的免疫表型。在感染FIV的无症状携带者猫中，DC的功能得以维持。本研究为开发FIV感染的抗病毒疗法提供了创新的发现。在RNA干扰、病毒受体、膜融合和DC等方面，猫的FIV感染与人类的艾滋病有显著的相似性，因此，本研究的结果也有助于利用猫系统作为人类艾滋病的动物模型。

项目成果

Verification of measurement of the feline serum amyloid A(SAA)concentration by human SAA turbidimetric immunoassay and its application

人SAA比浊免疫法测定猫血清淀粉样蛋白A(SAA)浓度的验证及其应用

• 发表时间: 2008
• 期刊: Journal of Veterinary Medical Science 70
• 作者: Tamamoto;T.;et al.
• 通讯作者: et al.

Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines.

应用RNA干扰抑制猫免疫缺陷病毒在慢性感染细胞系中的复制。

• 发表时间: 2007
• 期刊: Veterinary Microbiology 120
• 作者: Baba;K;et al.
• 通讯作者: et al.

Prevalence of canine distemper virus, feline immunodeficiency virus and feline leukemia virus in captive African lions(Panthers leo)in Japan

日本圈养非洲狮（Panthers leo）中犬瘟热病毒、猫免疫缺陷病毒和猫白血病病毒的流行情况

• 发表时间: 2005
• 期刊: Journal of Veterinary Medical Science 66
• 作者: Endo;Y.;et al.
• 通讯作者: et al.

Prevalence of canine distemper virus, feline immunodeficiency virus and feline leukemia virus in captive African lions (Panthera leo) in Japan

• DOI: 10.1292/jvms.66.1587
• 发表时间: 2004-12-01
• 期刊: JOURNAL OF VETERINARY MEDICAL SCIENCE
• 影响因子: 1.2
• 作者: Endo, Y;Uema, M;Kai, C
• 通讯作者: Kai, C

Characterization of monocyte-derived dendritic cells from cats infected with feline immunodeficiency virus.

感染猫免疫缺陷病毒的猫的单核细胞衍生树突状细胞的表征。

• 发表时间: 2009
• 期刊: The Journal of Veterinary Medical Science 71(7)
• 作者: 大塚弥生;大村俊弥;新敷信人;小松智彦;黒木一仁;佐藤耕太;稲葉睦;Mizukoshi F
• 通讯作者: Mizukoshi F